Evaluation Addressing the Core Issue: Presynaptic Modulation in Schizophrenia Using a Novel Class of Medication Evaluation HMP Education would appreciate your feedback on the quality and impact of this activity.Please answer the following questions, some of which include a 5-point Likert scale (5 = strongly agree/excellent/great deal; 1 = strongly disagree/poor/very little). Did this activity increase your knowledge (i.e., I now know what to do; New data presented; I learned something new)? Yes No Did this activity increase your competence or confidence in your abilities and skills (i.e., I know how to do something)? Yes No N/A - I am not practicing or am retired Did this activity improve your skills and attitudes that support your interprofessional healthcare team and delivery of patient care to improve outcomes? Yes No N/A - I am not practicing or am retired What attitudes, strategies, or skills did you take away from this CE activity related to interprofessional collaborative practice (when multiple health workers from different professional backgrounds work to deliver the highest quality of care)? 255 characters max Please rate the following related to this activity using a 5-point Likert scale: (5 = excellent, 3 = good, 1 = poor) Content information timely, up-to-date, and evidence-based 5 4 3 2 1 Relevance of this activity to your practice needs 5 4 3 2 1 Educational format clearly presented, organized, and met expectations 5 4 3 2 1 Overall activity rating/effectiveness, educational needs met 5 4 3 2 1 To what extent were the following learning objectives addressed by this activity: (5 = entirely, 3 = moderately, 1= not at all) Understand the role dopamine plays in schizophrenia 5 4 3 2 1 Identify the key differences between traditional versus novel mechanisms of action of schizophrenia treatments 5 4 3 2 1 Discuss the impact of newly approved and emerging pharmacotherapies on the schizophrenia treatment paradigm 5 4 3 2 1 How would you rate your level of knowledge BEFORE this activity: (5 = expert, 4 = very knowledgeable, 3 = somewhat knowledgeable, 2 = slightly knowledgeable, 1 = novice) Knowledge of schizophrenia 5 4 3 2 1 How would you rate your level of knowledge AFTER this activity: (5 = expert, 4 = very knowledgeable, 3= somewhat knowledgeable, 2 = slightly knowledgeable, 1 = novice) Knowledge of schizophrenia 5 4 3 2 1 Please rate the faculty on their knowledge, expertise, and teaching ability: (5 = excellent, 3 = good, 1 = poor) Greg Mattingly, MD 5 4 3 2 1 How many patients do you encounter with schizophrenia on a monthly basis? 10 or fewer 20 30 40 50 or more N/A What is your clinical practice setting? Community-based Hospital-based Research Academic Not in clinical practice Other The material presented in this activity was free of commercial influence. Agree Disagree, please explain instances of commercial influence Based on my participation in this activity, I intend to make changes to my practice: Yes No I am not practicing clinically or am retired Based on my participation in this activity, I anticipate I will more often (select all that apply): Detect and intervene in schizophrenia earlier (eg, in first-episode psychosis) Consult and cooperate with multidisciplinary team members in caring for patients with schizophrenia Evaluate the mechanisms of action of new/emerging treatments versus conventional treatments for schizophrenia Evaluate the clinical implications of new/emerging treatments for schizophrenia Discuss new and emerging treatments for schizophrenia with patients with schizophrenia Assess the appropriateness of available treatments for each patient with schizophrenia, taking both pharmacologic and patient-specific factors into consideration Engage in shared decision-making with patients with schizophrenia Other (please specify): Which of the following barriers do you perceive in your efforts to implement practice changes and/or optimize patient care? (select all that apply) Cost, insurance, and/or reimbursement issues Lack of administrative support Lack of consensus or professional guidelines Lack of experience, opportunity, and/or patients Lack of resources Systemic barriers (i.e. limited EHR, EMR, documentation systems) Lack of time to assess/counsel patients Patient compliance issues Lack of interprofessional communication or teamwork No barriers I am not in clinical practice Other How might future activities address barriers to change? 255 characters max As you look ahead, what CE topic is your highest learning priority to implement changes in your practice and positively impact patient care and outcomes? 255 characters max